Beam Therapeutics Inc.
BEAM
$23.91
$0.944.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.08% | 0.81% | -90.49% | -17.01% | -41.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.08% | 0.81% | -90.49% | -17.01% | -41.48% |
| Cost of Revenue | -21.12% | -10.84% | -27.58% | -5.79% | -80.74% |
| Gross Profit | 9.47% | 19.27% | -140.53% | 3.46% | 90.93% |
| SG&A Expenses | -9.34% | 4.55% | -33.74% | 4.35% | 20.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.24% | 13.64% | -29.03% | -3.74% | -4.58% |
| Operating Income | -14.54% | -14.55% | -175.30% | 1.63% | -2.69% |
| Income Before Tax | -12.39% | -10.74% | -162.67% | -0.60% | -9.95% |
| Income Tax Expenses | -- | -- | -100.00% | -- | -- |
| Earnings from Continuing Operations | -12.34% | -10.74% | -163.27% | -0.60% | -10.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.34% | -10.74% | -163.27% | -0.60% | -10.00% |
| EBIT | -14.54% | -14.55% | -175.30% | 1.63% | -2.69% |
| EBITDA | -15.40% | -15.26% | -168.44% | 1.99% | -2.04% |
| EPS Basic | 9.34% | -2.85% | -161.77% | 3.53% | -2.01% |
| Normalized Basic EPS | -1.04% | -4.55% | -160.91% | 0.19% | 13.25% |
| EPS Diluted | 9.34% | -2.85% | -163.44% | 3.53% | -2.01% |
| Normalized Diluted EPS | -1.04% | -4.55% | -162.31% | 0.19% | 13.25% |
| Average Basic Shares Outstanding | 23.91% | 7.68% | 2.43% | 4.28% | 7.83% |
| Average Diluted Shares Outstanding | 23.91% | 7.68% | 0.15% | 4.28% | 7.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |